1
|
Vandyousefi S, Oettingen G, Wittleder S, Moin T, Sweat V, Aguilar AD, Ruan A, Angelotti G, Wong L, Orstad SL, Illengberger N, Nicholson A, Lim S, Cansler R, Portelli D, Sherman S, Jay MR. Protocol for a prospective, randomized, controlled trial of Mental Contrasting with Implementation Intentions (MCII) to enhance the effectiveness of VA's MOVE! weight management program: WOOP (Wish, Outcome, Obstacle, Plan) VA. Contemp Clin Trials 2024; 141:107523. [PMID: 38608752 DOI: 10.1016/j.cct.2024.107523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Revised: 03/31/2024] [Accepted: 04/08/2024] [Indexed: 04/14/2024]
Abstract
INTRODUCTION Intensive weight management programs are effective but often have low enrollment and high attrition. Lack of motivation is a key psychological barrier to enrollment, engagement, and weight loss. Mental Contrasting with Implementation Intentions (MCII) is a unique imagery technique that increases motivation for behavior change. We describe our study protocol to assess the efficacy and implementation of MCII to enhance the effectiveness of VA's MOVE! or TeleMOVE! weight management programs using a procedure called "WOOP" (Wish, Outcome, Obstacle, Plan) for Veterans. We hypothesize that WOOP+MOVE! or TeleMOVE! (intervention) will lead to greater MOVE!/TeleMOVE! program engagment and consequently weight loss than MOVE!/TeleMOVE! alone (control). METHOD Veterans are randomized to either the intervention or control. Both arms receive the either MOVE! or TeleMOVE! weight management programs. The intervention group receives an hour long WOOP training while the control group receives patient education. Both groups receive telephone follow up calls at 3 days, 4 weeks, and 2 months post-baseline. Eligible participants are Veterans (ages 18-70 years) with either obesity (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 25 kg/m2) and an obesity-associated co-morbidity. At baseline, 6 and 12 months, we assess weight, diet, physical activity in both groups. The primary outcome is mean percent weight change at 6 months. Secondary outcomes include changes in waist circumference, diet, physical activity, and dieting self-efficacy and engagement in regular physical activity. We assess implementation using the RE-AIM framework. CONCLUSION If WOOP VA is found to be efficacious, it will be an important tool to facilitate weight management and improve weight outcomes. CLINICAL TRIAL REGISTRATION NCT05014984.
Collapse
Affiliation(s)
- Sarvenaz Vandyousefi
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Gabriele Oettingen
- Department of Psychology, New York University, New York, NY, United States of America
| | - Sandra Wittleder
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Tannaz Moin
- VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America; Department of Medicine, David Geffen School of Medicine, The University of California, Los Angeles, Los Angeles, CA, United States of America
| | - Victoria Sweat
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Adrian D Aguilar
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Andrea Ruan
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Gina Angelotti
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Laura Wong
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Stephanie L Orstad
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Nicholas Illengberger
- Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Andrew Nicholson
- Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Sahnah Lim
- Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Rachel Cansler
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Dilara Portelli
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Scott Sherman
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America; Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America
| | - Melanie R Jay
- New York Harbor Veterans Health Affairs, New York, NY, United States of America; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America; Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America.
| |
Collapse
|
2
|
Wittleder S, Viglione C, Reinelt T, Dixon A, Jagmohan Z, Orstad SL, Beasley JM, Wang B, Wylie-Rosett J, Jay M. Procedural Fairness in Physician-Patient Communication: A Predictor of Health Outcomes in a Cohort of Adults with Overweight or Obesity. Int J Behav Med 2024:10.1007/s12529-024-10282-6. [PMID: 38609688 DOI: 10.1007/s12529-024-10282-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/27/2024] [Indexed: 04/14/2024]
Abstract
BACKGROUND This study aimed to explore whether patients' perception of procedural fairness in physicians' communication was associated with willingness to follow doctor's recommendations, self-efficacy beliefs, dietary behaviors, and body mass index. METHODS This was a secondary analysis of baseline data from 489 primary care patients with a BMI ≥ 25 kg/m2 (43.6% Black, 40.7% Hispanic/Latino, 55.8% female, mean age = 50 years), who enrolled in a weight management study in two New York City healthcare institutions. We conducted ordinary least squares path analyses with bootstrapping to explore direct and indirect associations among procedural fairness, willingness to follow recommendations, self-efficacy, dietary behaviors, and body mass index, while controlling for age and gender. RESULTS Serial, multiple mediator models indicated that higher procedural fairness was associated with an increased willingness to follow recommendations which, in turn, was associated with healthier dietary behaviors and a lower BMI (indirect effect = - .02, SE = .01; 95% CI [- .04 to - .01]). Additionally, higher procedural fairness was associated with elevated dietary self-efficacy, which was, in turn, was associated with healthier dietary behaviors and lower BMI (indirect effect = - .01, SE = .003; 95% CI [- .02 to - .002]). CONCLUSIONS These findings highlight the importance of incorporating procedural fairness in physician-patient communication concerning weight management in diverse primary care patients.
Collapse
Affiliation(s)
- Sandra Wittleder
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
| | - Clare Viglione
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA
- Herbert Wertheim School of Public Health and Human Longevity Science, UC San Diego, San Diego, CA, USA
| | - Tilman Reinelt
- Department of Neonatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
| | - Alia Dixon
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA
| | - Zufarna Jagmohan
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA
| | - Stephanie L Orstad
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA
| | - Jeannette M Beasley
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA
- Department of Nutrition and Food Studies, Steinhardt School of Culture, Education, and Human Development Population Health, New York University, New York, NY, USA
| | - Binhuan Wang
- Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA
| | - Judith Wylie-Rosett
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, USA
| | - Melanie Jay
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA
- Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA
- Veterans Affairs New York Harbor Healthcare System, New York, NY, USA
| |
Collapse
|
3
|
Beasley JM, Johnston EA, Sevick MA, Jay M, Rogers ES, Zhong H, Zabar S, Goldberg E, Chodosh J. Study protocol: BRInging the Diabetes prevention program to GEriatric Populations. Front Med (Lausanne) 2023; 10:1144156. [PMID: 37275370 PMCID: PMC10232977 DOI: 10.3389/fmed.2023.1144156] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2023] [Accepted: 04/24/2023] [Indexed: 06/07/2023] Open
Abstract
In the Diabetes Prevention Program (DPP) randomized, controlled clinical trial, participants who were ≥ 60 years of age in the intensive lifestyle (diet and physical activity) intervention had a 71% reduction in incident diabetes over the 3-year trial. However, few of the 26.4 million American adults age ≥65 years with prediabetes are participating in the National DPP. The BRInging the Diabetes prevention program to GEriatric Populations (BRIDGE) randomized trial compares an in-person DPP program Tailored for Older AdulTs (DPP-TOAT) to a DPP-TOAT delivered via group virtual sessions (V-DPP-TOAT) in a randomized, controlled trial design (N = 230). Eligible patients are recruited through electronic health records (EHRs) and randomized to the DPP-TOAT or V-DPP-TOAT arm. The primary effectiveness outcome is 6-month weight loss and the primary implementation outcome is intervention session attendance with a non-inferiority design. Findings will inform best practices in the delivery of an evidence-based intervention.
Collapse
Affiliation(s)
- Jeannette M Beasley
- Department of Nutrition and Food Studies, New York University, New York, NY, United States
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States
| | - Emily A Johnston
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States
| | - Mary Ann Sevick
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States
- Department of Population Health, Institute for Excellence in Health Equity, New York University, New York, NY, United States
| | - Melanie Jay
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States
- Department of Population Health, Institute for Excellence in Health Equity, New York University, New York, NY, United States
- VA New York Harbor Healthcare System, Medicine Service, New York, NY, United States
| | - Erin S Rogers
- Department of Population Health, Institute for Excellence in Health Equity, New York University, New York, NY, United States
| | - Hua Zhong
- Department of Population Health, Institute for Excellence in Health Equity, New York University, New York, NY, United States
| | - Sondra Zabar
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States
| | - Eric Goldberg
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States
| | - Joshua Chodosh
- Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States
- Department of Population Health, Institute for Excellence in Health Equity, New York University, New York, NY, United States
- VA New York Harbor Healthcare System, Medicine Service, New York, NY, United States
| |
Collapse
|
4
|
Rosas LG, Lv N, Xiao L, Venditti EM, Lewis MA, Azar KMJ, Hooker SP, Zavella P, Ma J. HOMBRE: A Trial Comparing 2 Weight Loss Approaches for Latino Men. Am J Prev Med 2022; 63:341-353. [PMID: 35654660 DOI: 10.1016/j.amepre.2022.03.032] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 03/03/2022] [Accepted: 03/25/2022] [Indexed: 11/30/2022]
Abstract
INTRODUCTION Latino men have been drastically under-represented in research to identify effective behavioral weight-loss interventions. This trial compared 2 interventions for weight loss: (1) a culturally adapted intervention (HOMBRE) and (2) a minimal-intensity intervention. STUDY DESIGN Randomized controlled trial. SETTING/PARTICIPANTS Latino men with a BMI ≥27 kg/m2 and 1 or more cardiometabolic risk factors (N=424) were recruited (February 15, 2017‒October 2, 2018) from 14 medical centers and randomized to receive 1 of the 2 interventions. INTERVENTION HOMBRE provided men a choice among 3 options: coach-facilitated group sessions using online video conferencing, coach-facilitated group sessions in person, and prerecorded videos of group sessions available online. MAIN OUTCOME MEASURES The primary outcome was the proportion of participants sustaining clinically significant (≥5% of baseline) weight loss at 18 months. Secondary outcomes included weight loss trajectory over time, 3% and 10% weight loss, cardiometabolic risk factors, health behaviors, and psychosocial well-being at baseline and 18 months. Data were analyzed from October 6, 2020 to January 15, 2022. RESULTS Participants were predominantly middle aged (47.0 [SD=11.9] years), were married (74.3%), were with at least some college experience (79.7%), and had middle to upper incomes (72.4% with annual family incomes >$75,000). Their average BMI was 33.1 kg/m2 (SD=5.1). The proportion achieving clinically significant weight loss at 18 months was 27.4% in the HOMBRE intervention and 20.6% in the minimal-intensity intervention (mean difference=7.2%, 95% CI= -1.8, 17.0; p=0.13). Mean difference between the HOMBRE vs the minimal-intensity group was ‒1.25 kg at 6 months (95% CI= -2.28, -0.21; p=0.02) and ‒1.11 kg at 12 months (95% CI= -2.11, -0.10; p=0.03) using weight measurement data abstracted from the Electronic Health Record and by self report. There were no significant differences in secondary outcomes. CONCLUSIONS Among Latino men with overweight and obesity, HOMBRE was not more effective for clinically significant weight loss than a minimal-intensity intervention at 18 months.
Collapse
Affiliation(s)
- Lisa G Rosas
- Department of Epidemiology & Population Health, School of Medicine, Stanford University, Palo Alto, California.
| | - Nan Lv
- Department of Medicine, University of Illinois Chicago, Chicago, Illinois; Institute of Health Research and Policy, University of Illinois Chicago, Chicago, Illinois
| | - Lan Xiao
- Department of Epidemiology & Population Health, School of Medicine, Stanford University, Palo Alto, California
| | - Elizabeth M Venditti
- Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
| | - Megan A Lewis
- RTI Center for Communications Science, RTI International, Seattle, Washington
| | - Kristen M J Azar
- Sutter Health, Sutter Health Center for Health Systems Research, Palo Alto, California
| | - Steven P Hooker
- College of Health and Human Services, San Diego State University, San Diego, California
| | - Patricia Zavella
- Latin American and Latino Studies department, University of California Santa Cruz, Santa Cruz, California
| | - Jun Ma
- Department of Medicine, University of Illinois Chicago, Chicago, Illinois; Institute of Health Research and Policy, University of Illinois Chicago, Chicago, Illinois
| |
Collapse
|
5
|
Fang Y, He W. Practical considerations in utilizing cluster randomized controlled trials conducted in biopharmaceutical industry. Clin Trials 2022; 19:416-421. [DOI: 10.1177/17407745211073484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Cluster randomized controlled trials (cluster RCTs), also known as parallel-arm group-randomized trials, are trials in which the randomized units are groups of participants, as opposed to individual participants. These trials have largely been implemented to address broad public health issues, but with the growing interest in use of real-world data in the regulatory setting, this design may be increasingly considered for industry trials. The key difference between cluster RCTs and traditional RCTs is the intraclass correlation coefficient (ICC) that needs to be considered in cluster RCTs. In this article, we discuss some key practical considerations that are related to ICC in the design, conduct, analysis, and report stages of a cluster RCT. These key considerations related to ICC can lead to improvement in how we translate research findings from cluster RCTs into practices in the biopharmaceutical industry.
Collapse
|
6
|
Merriwether EN, Wittleder S, Cho G, Bogan E, Thomas R, Bostwick N, Wang B, Ravenell J, Jay M. Racial and weight discrimination associations with pain intensity and pain interference in an ethnically diverse sample of adults with obesity: a baseline analysis of the clustered randomized-controlled clinical trial the goals for eating and moving (GEM) study. BMC Public Health 2021; 21:2201. [PMID: 34856961 PMCID: PMC8638106 DOI: 10.1186/s12889-021-12199-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2021] [Accepted: 10/18/2021] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Everyday experiences with racial (RD) and weight discrimination (WD) are risk factors for chronic pain in ethnically diverse adults with obesity. However, the individual or combined effects of RD and WD on pain in adults with obesity is not well understood. There are gender differences and sexual dimorphisms in nociception and pain, but the effect of gender on relationships between RD, WD, and pain outcomes in ethnically diverse adults with obesity is unclear. Thus, the purposes of this study were to: 1) examine whether RD and WD are associated with pain intensity and interference, and 2) explore gender as a moderator of the associations between RD, WD, and pain. METHODS This is a baseline data analysis from a randomized, controlled clinical trial of a lifestyle weight-management intervention. Eligible participants were English or Spanish-speaking (ages 18-69 years) and had either a body mass index of ≥30 kg/m2 or ≥ 25 kg/m2 with weight-related comorbidity. RD and WD were measured using questions derived from the Experiences of Discrimination questionnaire (EOD). Pain interference and intensity were measured using the PROMIS 29 adult profile V2.1. Linear regression models were performed to determine the associations between WD, RD, gender, and pain outcomes. RESULTS Participants (n = 483) reported mild pain interference (T-score: 52.65 ± 10.29) and moderate pain intensity (4.23 ± 3.15). RD was more strongly associated with pain interference in women (b = .47, SE = .08, p < 001), compared to men (b = .14, SE = .07, p = .06). Also, there were no significant interaction effects between RD and gender on pain intensity, or between WD and gender on pain interference or pain intensity. CONCLUSIONS Pain is highly prevalent in adults with obesity, and is impacted by the frequencies of experiences with RD and WD. Further, discrimination against adults with obesity and chronic pain could exacerbate existing racial disparities in pain and weight management. Asking ethnically diverse adults with obesity about their pain and their experiences of RD and WD could help clinicians make culturally informed assessment and intervention decisions that address barriers to pain relief and weight loss. TRIAL REGISTRATION NCT03006328.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Melanie Jay
- NYU Grossman School of Medicine, New York, USA
- New York Harbor VA, New York, USA
| |
Collapse
|
7
|
Wittleder S, Smith S, Wang B, Beasley JM, Orstad SL, Sweat V, Squires A, Wong L, Fang Y, Doebrich P, Gutnick D, Tenner C, Sherman SE, Jay M. Peer-Assisted Lifestyle (PAL) intervention: a protocol of a cluster-randomised controlled trial of a health-coaching intervention delivered by veteran peers to improve obesity treatment in primary care. BMJ Open 2021; 11:e043013. [PMID: 33637544 PMCID: PMC7919589 DOI: 10.1136/bmjopen-2020-043013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
INTRODUCTION Among US veterans, more than 78% have a body mass index (BMI) in the overweight (≥25 kg/m2) or obese range (≥30 kg/m2). Clinical guidelines recommend multicomponent lifestyle programmes to promote modest, clinically significant body mass (BM) loss. Primary care providers (PCPs) often lack time to counsel and refer patients to intensive programmes (≥6 sessions over 3 months). Using peer coaches to deliver obesity counselling in primary care may increase patient motivation, promote behavioural change and address the specific needs of veterans. We describe the rationale and design of a cluster-randomised controlled trial to test the efficacy of the Peer-Assisted Lifestyle (PAL) intervention compared with enhanced usual care (EUC) to improve BM loss, clinical and behavioural outcomes (aim 1); identify BM-loss predictors (aim 2); and increase PCP counselling (aim 3). METHODS AND ANALYSIS We are recruiting 461 veterans aged 18-69 years with obesity or overweight with an obesity-associated condition under the care of a PCP at the Brooklyn campus of the Veterans Affairs NY Harbor Healthcare System. To deliver counselling, PAL uses in-person and telephone-based peer support, a tablet-delivered goal-setting tool and PCP training. Patients in the EUC arm receive non-tailored healthy living handouts. In-person data collection occurs at baseline, month 6 and month 12 for patients in both arms. Repeated measures modelling based on mixed models will compare mean BM loss (primary outcome) between study arms. ETHICS AND DISSEMINATION The protocol has been approved by the Institutional Review Board and the Research and Development Committee at the VA NY Harbor Health Systems (#01607). We will disseminate the results via peer-reviewed publications, conference presentations and meetings with stakeholders. TRIAL REGISTRATION NUMBER NCT03163264; Pre-results.
Collapse
Affiliation(s)
- Sandra Wittleder
- Department of Medicine, New York University School of Medicine, New York City, New York, USA
| | - Shea Smith
- Department of Medicine, New York University School of Medicine, New York City, New York, USA
| | - Binhuan Wang
- Department of Population Health, New York University School of Medicine, New York City, New York, USA
| | - Jeannette M Beasley
- Department of Medicine, New York University School of Medicine, New York City, New York, USA
| | - Stephanie L Orstad
- Department of Medicine, New York University School of Medicine, New York City, New York, USA
| | - Victoria Sweat
- Department of Medicine, New York University School of Medicine, New York City, New York, USA
| | - Allison Squires
- Rory Meyers College of Nursing, New York University, New York City, New York, USA
| | - Laura Wong
- Department of Medicine, New York University School of Medicine, New York City, New York, USA
| | - Yixin Fang
- Department of Population Health, New York University School of Medicine, New York City, New York, USA
| | - Paula Doebrich
- Department of Medicine, New York University School of Medicine, New York City, New York, USA
| | - Damara Gutnick
- Department of Epidemiology & Population Health, Department of Family & Social Medicine, Department of Psychiatry & Behavioral Sciences, The Albert Einstein College of Medicine, Bronx, New York, USA
| | - Craig Tenner
- Department of Medicine, New York University School of Medicine, New York City, New York, USA
- Veterans Affairs New York Harbor Healthcare System, Veterans Health Administration, New York City, New York, USA
| | - Scott E Sherman
- Veterans Affairs New York Harbor Healthcare System, Veterans Health Administration, New York City, New York, USA
- Department of Population Health, Department of Medicine, Department of Psychiatry, New York University School of Medicine, New York City, New York, USA
| | - Melanie Jay
- Veterans Affairs New York Harbor Healthcare System, Veterans Health Administration, New York City, New York, USA
- Department of Medicine, Department of Population Health, New York University School of Medicine, New York City, New York, USA
| |
Collapse
|